ProFrac reported Q4 2024 revenue of $455 million, down from $575 million in the prior quarter. The company posted a net loss of $102 million, reflecting adverse market conditions and lower activity levels. Adjusted EBITDA fell to $71 million, down from $135 million in Q3. The Stimulation Services segment remained the largest revenue contributor at $384 million. ProFrac expects market conditions to improve in 2025 with increased fleet deployment and better operational efficiency.
Revenue declined to $455 million from $575 million in Q3 due to pricing pressure and seasonal budget exhaustion.
Net loss widened to $102 million from $44 million in Q3, reflecting weaker market conditions.
Adjusted EBITDA dropped to $71 million from $135 million in Q3 as margins contracted.
Stimulation Services remained the largest segment, generating $384 million in revenue.
ProFrac anticipates improved market conditions in 2025 with increased fleet deployment and enhanced operational efficiencies.
Visualization of income flow from segment revenue to net income